MoneyWorks4Me

Biocon informs about analyst meet

01 Dec 2022 Evaluate
Pursuant to Regulation 30(6) of the SEBI LODR Regulations, 2015, Biocon has informed that meetings were conducted with Institutional Investor/ Research Analysts as on November 30, 2022. Further details enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.90
Dr. Reddys Labs. 1196.70
Cipla 1335.60
Lupin 2010.65
Zydus Lifesciences 1143.85
View more..